Codexis Announces New Employment Inducement Grants
16 août 2024 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to three new employees as...
Codexis Publishes FY2023 Sustainability Disclosures
15 août 2024 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the publication of its inaugural sustainability...
Codexis Reports Second Quarter 2024 Financial Results
08 août 2024 16h05 HE
|
Codexis, Inc.
Company Reiterates Full-year Financial Guidance; On Track to Achieve Product Revenue Growth of at Least 10% vs. FY2023 Excluding Enzyme Sales Related to PAXLOVID™ Anticipate Entering First Technical...
Codexis to Report Second Quarter 2024 Financial Results on August 8
18 juil. 2024 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the second...
Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets
01 juil. 2024 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into an asset purchase agreement with...
Codexis to Participate in Jefferies Global Healthcare Conference
22 mai 2024 16h25 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Jefferies Global Healthcare...
Codexis to Participate in TD Cowen 2nd Annual Sustainability Week
20 mai 2024 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will participate in a panel discussion titled,...
Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
14 mai 2024 06h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has successfully synthesized an oligonucleotide via an...
Codexis Reports First Quarter 2024 Financial Results
02 mai 2024 16h05 HE
|
Codexis, Inc.
Q1 Total Revenue Up 32% Year-over-year, Including Product Revenue Up 14%; Company Reiterates 2024 Financial Guidance First Substantial Order for dsRNA Ligase Received from Large Pharma Customer ...
Codexis to Report First Quarter 2024 Financial Results on May 2
18 avr. 2024 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the first...